Evidence map›Paper›PMID 22116357›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2011

Pendrin function and regulation in Xenopus oocytes.

Fabian R Reimold, John F Heneghan, Andrew K Stewart, Israel Zelikovic, David H Vandorpe, Boris E Shmukler, Seth L Alper

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. SLC26 Anion Transporters.Handbook of experimental pharmacology · 2024
    Review
  5. Cross-species applicability of an adverse outcome pathway network for thyroid hormone system disruption.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Pendrin localizes to the adrenal medulla and modulates catecholamine release.American journal of physiology. Endocrinology and metabolism · 2015
    Article
  12. The multiple roles of pendrin in the kidney.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2015
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Fabian R ReimoldRenal Division and Molecular and Vascular Medicine Unit, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
John F Heneghan
Andrew K Stewart
Israel Zelikovic
David H Vandorpe
Boris E Shmukler
Seth L Alper
Harvard University · USRambam Health Care Campus · IL

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4M
TRAINING IN PEDIATRIC GASTROENTEROLOGY &NUTRITIONT32DK007477 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI Scott B Snapper · 1986 to 2026
$13.3M
RESEARCH TRAINING IN NEPHROLOGYT32DK007199 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI POLLAK, MARTIN R. · 1986 to 2022
$6.0M
MOLECULAR PHYSIOLOGY OF BAND 3 LIKE PROTEINS OF KIDNEYR37DK043495 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ALPER, SETH LEO · 1998 to 2007
$3.0M
RBC Ion Transporters as Hemoglobinopathy Risk ModifiersR01HL077765 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ALPER, SETH LEO · 2006 to 2009
$1.6M
BASIC RESEARCH TRAINING FOR DIABETES OR ENDOCRINOLOGYT32DK007094 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KAPLAN, SOLOMON A. · 1986 to 1987
–
MOLECULAR PHYSIOLOGY OF BAND 3-LIKE PROTEINS OF KIDNEYR01DK043495 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ALPER, SETH LEO · 1991 to 1997
–
NHLBI NIH HHS HL077765NHLBI NIH HHS R01 HL077765NIDDK NIH HHS DK007199NIDDK NIH HHS DK07094NIDDK NIH HHS DK07477NIDDK NIH HHS DK34854NIDDK NIH HHS P30 DK034854NIDDK NIH HHS R01 DK43495NIDDK NIH HHS R37 DK043495NIDDK NIH HHS T32 DK007199NIDDK NIH HHS T32 DK007477
6 · The paper itself

Abstract

SLC26A4/PDS mutations cause Pendred Syndrome and non-syndromic deafness. but some aspects of function and regulation of the SLC26A4 polypeptide gene product, pendrin, remain controversial or incompletely understood. We have therefore extended the functional analysis of wildtype and mutant pendrin in Xenopus oocytes, with studies of isotopic flux, electrophysiology, and protein localization. Pendrin mediated electroneutral, pH-insensitive, DIDS-insensitive anion exchange, with extracellular K((1/2)) (in mM) of 1.9 (Cl(-)), 1.8 (I(-)), and 0.9 (Br(-)). The unusual phenotype of Pendred Syndrome mutation E303Q (loss-of-function with normal surface expression) prompted systematic mutagenesis at position 303. Only mutant E303K exhibited loss-of-function unrescued by forced overexpression. Mutant E303C was insensitive to charge modification by methanethiosulfonates. The corresponding mutants SLC26A2 E336Q, SLC26A3 E293Q, and SLC26A6 E298Q exhibited similar loss-of-function phenotypes, with wildtype surface expression also documented for SLC26A2 E336Q. The strong inhibition of wildtype SLC26A2, SLC26A3, and SLC26A6 by phorbol ester contrasts with its modest inhibition of pendrin. Phorbol ester inhibition of SLC26A2, SLC26A3, and SLC26A6 was blocked by coexpressed kinase-dead PKCδ but was without effect on pendrin. Mutation of SLC26A2 serine residues conserved in PKCδ -sensitive SLC26 proteins but absent from pendrin failed to reduce PKCδ sensitivity of SLC26A2 (190).

Indexed as

Gene Expression Regulation, Developmental4,4'-Diisothiocyanostilbene-2,2'-Disulfonic AcidAmino Acid SequenceAmino Acid SubstitutionAnimalsAnionsGoiter, NodularHearing Loss, SensorineuralHydrogen-Ion ConcentrationIon TransportMembrane Transport ProteinsMesylatesMolecular Sequence DataMutagenesisOocytesPhenotype4,4'-Diisothiocyanostilbene-2,2'-Disulfonic AcidAnionsMembrane Transport ProteinsMesylatesmethanethiosulfonatePhorbol EstersProtein Kinase C-deltaSLC26A4 protein, humanSulfate Transporters

Identifiers

PMID22116357
PMCPMC3709188
OpenAlexW1964736632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.